Evidence map›Paper›PMID 36267845›Full record

ArticleBioMed research international2022

Prediction Model of Residual Neural Network for Pathological Confirmed Lymph Node Metastasis of Ovarian Cancer.

Huanchun Yao, Xinglong Zhang

Abstract read
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Huanchun YaoDepartment of Cancer, Shengjing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004 Liaoning Province, China.ORCID https://orcid.org/0000-0002-1040-2324
Xinglong ZhangDepartment of Hematology, The Fourth Affiliated Hospital of China Medical University, Shenyang, 110032 Liaoning Province, China.ORCID https://orcid.org/0000-0002-4116-949X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We want to develop a model for predicting lymph node status based on positron emission computed tomography (PET) images of untreated ovarian cancer patients. We use the feature map formed by wavelet transform and the parameters obtained by image segmentation to build the model. The model is expected to help clinicians and provide additional information about what to do with first-visit patients. Materials and Methods: Our study included 224 patients with ovarian cancer. We have chosen two main methods to extract information from images. On the one hand, we segmented the image to extract the parameters to evaluate the clustering effect. On the other hand, we used wavelet transform to extract the image's texture information to form the image's feature map. Based on the above two kinds of information, we used residual neural network and support vector machine for modeling. Results: We established a model to predict lymph node metastasis in patients with primary ovarian cancer using PET images. On the training set, our accuracy was 0.8854, AUC: 0.9472, CI: 0.9098-0.9752, sensitivity was 0.9865, and specificity was 0.7952. On the test set, our accuracy was 0.9104, AUC: 0.9259, CI: 0.8417-0.9889, sensitivity was 0.8125, and specificity was 1.0000. Conclusions: We used wavelet transform to process the preoperative medical images of ovarian cancer patients, and the residual neural network can effectively predict the lymph node metastasis of ovarian cancer patients, which is undoubted of great significance for patients' staging and treatment options.

Indexed as

Neural Networks, ComputerOvarian NeoplasmsCarcinoma, Ovarian EpithelialFemaleHumansLymphatic MetastasisLymph NodesPositron-Emission TomographyPositron Emission Tomography Computed TomographyRetrospective Studies

Identifiers

PMID36267845
PMCPMC9578811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.